181 related articles for article (PubMed ID: 34764108)
21. Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence.
Roman J; Andres P; Jimenez MA; Torres A
Br J Haematol; 1994 Jul; 87(3):624-6. PubMed ID: 7993807
[TBL] [Abstract][Full Text] [Related]
22. Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinib.
Nakajima R; Matsuo T; Sumiyoshi R; Saito S; Yamamoto T; Matsumoto K; Akiyama N; Ooi J; Ota Y; Shirafuji N; Tashiro H
Br J Haematol; 2022 Jan; 196(1):e9-e11. PubMed ID: 34378212
[No Abstract] [Full Text] [Related]
23. A case of chronic myeloid leukaemia in blast transformation with leukemic ascites.
Mohd Ridzuan MS; Yap E; Wan Fariza WJ; Fadilah SA; Salwati S
Med J Malaysia; 2016 Apr; 71(2):85-7. PubMed ID: 27326952
[TBL] [Abstract][Full Text] [Related]
24. [Extramedullary blast crisis in chronic myeloid leukemia].
Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors, Response to Treatment, and Survival in Patients With Chronic Myeloid Leukemia in Blast Phase: A Single-Institution Survey.
Pérez-Jacobo F; Tuna-Aguilar E; Demichelis-Gómez R; Crespo-Solís E; Valencia-Rocha U; Aguayo Á; López-Karpovitch X
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):778-84. PubMed ID: 26500135
[TBL] [Abstract][Full Text] [Related]
26. [Extramedullary blast crisis of mixed precursor T lymphoblastic and myeloblastic features in a patient with chronic myelogenous leukemia successfully treated with low-dose oral etoposide].
Konaka Y; Namiuchi S
Rinsho Ketsueki; 1993 Dec; 34(12):1556-61. PubMed ID: 8295329
[TBL] [Abstract][Full Text] [Related]
27. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
Ganessan K; Goel R; Kumar K; Bakhshi S
Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
[TBL] [Abstract][Full Text] [Related]
28. Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
Jain N; Maiti A; Ravandi F; Konopleva M; Daver N; Kadia T; Pemmaraju N; Short N; Kebriaei P; Ning J; Cortes J; Jabbour E; Kantarjian H
Am J Hematol; 2021 Aug; 96(8):1000-1007. PubMed ID: 33991360
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
[TBL] [Abstract][Full Text] [Related]
30. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
31. Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia.
Maia RC; Noronha H; Vasconcelos FC; Rumjanek VM
Clin Lab Haematol; 1997 Sep; 19(3):215-7. PubMed ID: 9352149
[TBL] [Abstract][Full Text] [Related]
32. Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia.
Nair IM; Feroze M; Aravindan KP
Indian J Pathol Microbiol; 2016; 59(1):107-9. PubMed ID: 26960653
[TBL] [Abstract][Full Text] [Related]
33. Central nervous system blast crisis of chronic myeloid leukaemia misdiagnosed as tubercular meningitis.
Kumawat BL; Sharma CM; Saini PK; Garg A
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895576
[TBL] [Abstract][Full Text] [Related]
34. How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety.
Perrone S; Massaro F; Alimena G; Breccia M
Expert Opin Pharmacother; 2016 Aug; 17(11):1517-26. PubMed ID: 27231757
[TBL] [Abstract][Full Text] [Related]
35. ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.
Perrotti D; Neviani P
Br J Cancer; 2006 Oct; 95(7):775-81. PubMed ID: 16953242
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia.
González FA; Villegas A; Ferro MT; Cabello P; Morales D; Perez J; Martinez R
Br J Haematol; 1993 Jun; 84(2):351-2. PubMed ID: 8398844
[TBL] [Abstract][Full Text] [Related]
37. Extramedullary blast crisis in chronic myeloid leukemia--a case report.
Tondon R; Singh PA; Misra V; Singh M; Mohan S
Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687
[TBL] [Abstract][Full Text] [Related]
38. Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases.
Gu R; Zhang W; Xu D
Pharm Biol; 2022 Dec; 60(1):700-707. PubMed ID: 35348419
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease.
Gambacorti-Passerini C; Barni R; Marchesi E; Verga M; Rossi F; Rossi F; Pioltelli P; Pogliani E; Corneo GM
Br J Haematol; 2001 Mar; 112(4):972-4. PubMed ID: 11298594
[TBL] [Abstract][Full Text] [Related]
40. B-Lymphoid Blast Phase-Chronic Myeloid Leukemia: Current Therapeutics.
Yohannan B; George B
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
